Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Akt1 S1834-p
AMPKA1 S89-p
ATM S106-p
CDK1 S1038-p , S2039-p
ERK1 S1038-p , S2039-p
ERK2 S1038-p , S2039-p , S2279-p , S2315-p , S2366-p
HIPK2 S2279-p
P38B S12-p
PKCA S89-p
PKCD S89-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

Akt1 S1834-p
AMPKA1 S89-p
ATM S106-p
CDK1 S1038-p , S2039-p
ERK2 T317-p , T938-p , T1960-p , S2279-p , S2315-p , S2366-p
PKCD S89-p
Regulatory protein:
AML1 S831-p , S833-p , T839-p , T841-p , T845-p , T885-p , T887-p
C/EBP-beta S2279-p
HIPK2 S2279-p
P38A S12-p
PLK1 S1577-p , S1581-p
SIRT1 K489-ac
TLR4 S12-p
Treatment:
acadesine S89-p
calphostin_C S89-p
celastrol S2279-p
conditioned medium S12-p
cycloheximide S1038-p , S2039-p
EGF S2279-p , S2315-p , S2366-p
etoposide S106-p
gefitinib Y611-p , Y620-p
Go_6976 S89-p
ionizing_radiation S106-p
ischemia S285-p
LY294002 S1834-p
metformin S89-p
MS275 K636-ac , K977-ac , K1180-ac , K1499-ac , K1542-ac , K1546-ac , K1554-ac , K1555-ac , K1558-ac , K1560-ac , K1583-ac , K1590-ac , K1674-ac
nicotinamide K1020-ac , K1024-ac
nilotinib S12-p
nocodazole S1038-p , S2039-p
phenylephrine S89-p
phorbol_ester S89-p
resveratrol K489-ac
Ro31-8220 S89-p
rottlerin S89-p
SB202190 S12-p
SB203580 S1834-p
seliciclib S1038-p , S2039-p
SH-5 S1834-p
siRNA S12-p , S1038-p , S2039-p
TNF S1834-p
TPO S89-p
trichostatin_A K1020-ac , K1024-ac
U0126 S1038-p , S2039-p , S2279-p , S2315-p , S2366-p
UV S1834-p
vorinostat K981-ac , K1499-ac , K1542-ac , K1546-ac , K1549-ac , K1550-ac , K1554-ac , K1555-ac , K1558-ac , K1560-ac , K1583-ac , K1590-ac , K1674-ac